PATENT CLAIM ANALYSIS

Application Number: 16396400
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "402000"]

Abstract:
The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.

Claim (Index 18):
The article of  claim 4 , wherein the article is free of controlled release excipient, free of a crystallization inhibiting excipient, free of a mechanical integrity enhancing excipient, and/or free of a binding excipient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.32
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16396135', '13006801', '14795819', '11236426', '14300030']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.657440495733225
- 35 USC 102 Novelty (BERT): 0.558616038239802
- Combined Prediction Score: 0.6475580499838828
- Mean Citation Score: 224.19338
- Max Citation Score: 480.0642
- Similarity Product: 247.875785060978

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test